8-KOther EventsExhibits & Filings

UNITEDHEALTH GROUP INC 8-K Report, Corporate Update (Mar 7, 2005)

Filed March 7, 2005For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) filed an 8-K on March 7, 2005, reporting on a significant debt financing transaction. The company announced the sale of $500 million in aggregate principal amount of 4.875% Notes due March 15, 2015. This offering was facilitated through an Underwriting Agreement with prominent financial institutions including Citigroup Global Markets Inc., J.P. Morgan Securities Inc., and Morgan Stanley & Co. Incorporated. This debt issuance represents a strategic move by UnitedHealth Group to potentially fund ongoing operations, strategic initiatives, or refinance existing debt. The specific terms of the notes, including the interest rate of 4.875% and the maturity date of March 15, 2015, provide clarity on the cost of capital for this issuance. The registration of these notes under the Securities Act of 1933 indicates compliance with regulatory requirements for public offerings.

Key Highlights

  • 1Announced sale of $500 million in aggregate principal amount of 4.875% Notes due March 15, 2015.
  • 2The offering was conducted under an Underwriting Agreement dated March 2, 2005.
  • 3Key underwriters include Citigroup Global Markets Inc., J.P. Morgan Securities Inc., and Morgan Stanley & Co. Incorporated.
  • 4The notes are issued pursuant to the company's Senior Debt Securities Indenture, dated November 15, 1998, as amended.
  • 5The issuance of the Notes was scheduled for March 7, 2005.
  • 6The notes have been registered under the Securities Act of 1933 via a Form S-3 registration statement.

Frequently Asked Questions

This 8-K filing serves to publicly announce UnitedHealth Group's agreement to sell $500 million in notes to the public. It details the terms of the debt issuance and the parties involved in the underwriting process.

The notes have an aggregate principal amount of $500 million, a coupon rate of 4.875%, and are due on March 15, 2015. They are governed by the company's existing Senior Debt Securities Indenture.

The primary underwriters for this offering are Citigroup Global Markets Inc., J.P. Morgan Securities Inc., and Morgan Stanley & Co. Incorporated, acting as Representatives of the several Underwriters.

While the filing does not explicitly state the use of proceeds, debt issuances of this nature are typically used to fund general corporate purposes, such as acquisitions, capital expenditures, refinancing existing debt, or to strengthen the company's liquidity position.